Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.8K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.8K
Cell Lines01:16

Cell Lines

10.3K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
10.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

16.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.0K
What is Variation?01:14

What is Variation?

18.4K
Apart from the measures of central tendency, distribution, outliers, and the changing characteristics of data with time, an important characteristic of any data set is its variation or spread. In some data sets, the data values are concentrated closely near the mean; in others, the data values are more widely spread out from the mean.
The range, standard deviation, standard error, and variance are the different measures of variation.
Range: The range is the difference between its maximum and...
18.4K
Variation01:19

Variation

8.0K
An important characteristic of any set of data is the variation in the data. In some data sets, the data values are concentrated closely near the mean; in other data sets, the data values are more widely spread out from the mean. The most common measure of variation, or spread, is the standard deviation, which is the square root of variance.
When independent and dependent variables are plotted on a scatter plot, the slope of a line is a value that describes the rate of change between the two...
8.0K
Recombinant DNA01:09

Recombinant DNA

102.2K
Overview
102.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Highly Stringent Split Intein-Mediated DHFR Selectable Marker Enables Efficient Development of High-Producing CHO Cells for Therapeutic Proteins.

ACS synthetic biology·2026
Same author

CRISPR-Cas9 screening reveals <i>TM9SF2</i> knockout as a solution to HEK293 cell aggregation for improved AAV production.

Molecular therapy. Advances·2026
Same author

Quantitative Proteomics and CRISPR/Cas9 Editing Reveal UPR-Mediated Control of Immunoglobulin Homeostasis in Hybridomas.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Tracing the contrasting fates of terrestrial and marine organic matter in coastal waters using stable carbon isotopes.

Marine pollution bulletin·2025
Same author

CRISPR screen-based mammalian cell engineering for complex biotherapeutics.

Trends in biotechnology·2025
Same author

Genome-wide CRISPR screening identifies genes in recombinant human embryonic kidney 293 cells for increased ammonia resistance.

Metabolic engineering·2025

Related Experiment Video

Updated: Jan 27, 2026

Anaerobic Growth and Maintenance of Mammalian Cell Lines
07:15

Anaerobic Growth and Maintenance of Mammalian Cell Lines

Published on: July 21, 2018

10.7K

Mitigating Clonal Variation in Recombinant Mammalian Cell Lines.

Jae Seong Lee1, Helene Faustrup Kildegaard2, Nathan E Lewis3

  • 1Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea; The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.

Trends in Biotechnology
|March 23, 2019
PubMed
Summary
This summary is machine-generated.

Developing recombinant mammalian cell lines for therapeutic proteins can be challenging due to cell variation. This study introduces a novel platform using targeted integration to minimize clonal variation and predict phenotypes for improved production.

Keywords:
cell line developmentclonal variationrational cell engineeringtransgene integration

More Related Videos

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

23.2K
Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
09:40

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9

Published on: January 3, 2015

96.5K

Related Experiment Videos

Last Updated: Jan 27, 2026

Anaerobic Growth and Maintenance of Mammalian Cell Lines
07:15

Anaerobic Growth and Maintenance of Mammalian Cell Lines

Published on: July 21, 2018

10.7K
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

23.2K
Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
09:40

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9

Published on: January 3, 2015

96.5K

Area of Science:

  • Biotechnology and Bioprocessing
  • Mammalian Cell Culture for Therapeutics

Background:

  • Mammalian expression systems are crucial for producing therapeutic proteins with complex post-translational modifications.
  • Current recombinant mammalian cell line development often results in significant phenotypic heterogeneity, complicating research and production.
  • Advances in genome editing and systems biotechnology offer new tools to understand and control cellular variation.

Purpose of the Study:

  • To propose a next-generation cell line development platform designed to minimize clonal variation in mammalian expression systems.
  • To enable rational cell engineering for predictable recombinant gene expression and desired phenotypes.

Main Methods:

  • Utilizing advanced mammalian genome-editing technologies.
  • Implementing systems biotechnology approaches for rational cell engineering.
  • Employing targeted integration strategies with knowledge-based selection of integration sites and engineering targets.

Main Results:

  • The proposed platform aims to significantly reduce phenotypic heterogeneity among clonal cell lines.
  • Targeted integration allows for precise control over recombinant gene expression.
  • This approach facilitates the development of cell lines with predictable and desired phenotypes.

Conclusions:

  • A novel targeted integration-based cell line development platform can overcome the challenge of clonal variation in mammalian expression systems.
  • This strategy offers tailored control over recombinant protein production, leading to more consistent and predictable outcomes.
  • The platform represents a significant advancement for the efficient and reliable development of therapeutic protein-producing cell lines.